Pentoxifylline Applications in Diabetic Kidney Disease
Summary
Pentoxifylline is a non-selective phosphodiesterase inhibitor with anti-inflammatory, antioxidant and haemorheologic properties that has been explored as an adjuvant therapy in diabetic kidney disease. In DKD, characterised by progressive albuminuria, declining glomerular filtration rate and heightened cardiovascular risk, inflammation and oxidative stress drive tissue injury. By reducing proinflammatory cytokines such as TNF-α, improving renal perfusion and attenuating fibrotic signalling, pentoxifylline has demonstrated antiproteinuric effects and slowed loss of renal function in clinical studies. Emerging evidence also suggests modulation of the Klotho axis, which may underpin vascular and renoprotective benefits. Long-term administration appears to reduce cardiovascular events in DKD patients, extending its potential role into primary prevention strategies. Global trials have reported favourable safety profiles, with minimal serious adverse events, supporting its repositioning as a cost-effective complement to standard glycaemic and blood pressure management. Practical applications include reduction of albumin/creatinine ratio, improvement in estimated glomerular filtration rate trajectory and mitigation of endothelial dysfunction. Such multifaceted actions underscore pentoxifylline’s promise in addressing the inflammatory and oxidative pathways central to DKD progression.
Research from Nature Portfolio
No recent Nature Portfolio content available.
Pentoxifylline Applications in Diabetic Kidney Disease publication trend
The graph below shows the total number of articles in pentoxifylline applications in diabetic kidney disease across all publications each year (not limited to Nature Index journals).
Technical terms
Pentoxifylline: A non-selective phosphodiesterase inhibitor with anti-inflammatory and haemorheologic actions used to improve microcirculatory flow.
Diabetic kidney disease (DKD): A progressive renal complication of diabetes marked by albuminuria, declining glomerular filtration rate and increased cardiovascular risk.
Albuminuria: The presence of albumin in urine, often expressed as albumin/creatinine ratio, indicating glomerular injury.
Estimated glomerular filtration rate (eGFR): A calculated measure of renal function based on serum creatinine, age and other variables.
Klotho: A renal-expressed protein with anti-aging and vascular protective properties frequently diminished in CKD.
Proinflammatory cytokines: Signalling proteins such as TNF-α that mediate inflammation and contribute to kidney tissue damage.
References
- Diabetic Kidney Disease: Pathophysiology and Therapeutic Targets. Journal of Diabetes Research (2015).
- Pentoxifylline for Renal Protection in Diabetic Kidney Disease. A Model of Old Drugs for New Horizons. Journal of Clinical Medicine (2019).
- Long-Term Pentoxifylline Therapy Is Associated with a Reduced Risk of Atherosclerotic Cardiovascular Disease by Inhibiting Oxidative Stress and Cell Apoptosis in Diabetic Kidney Disease Patients. Antioxidants (2024).
- Tadalafil versus pentoxifylline in the management of diabetic kidney disease: a randomized clinical trial. Diabetology & Metabolic Syndrome (2024).
About these summaries
This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.